Logo image of HCWB

HCW BIOLOGICS INC (HCWB) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:HCWB - US40423R2040 - Common Stock

1.98 USD
-0.06 (-2.94%)
Last: 12/5/2025, 8:25:49 PM
1.9 USD
-0.08 (-4.04%)
After Hours: 12/5/2025, 8:25:49 PM
Fundamental Rating

1

Overall HCWB gets a fundamental rating of 1 out of 10. We evaluated HCWB against 534 industry peers in the Biotechnology industry. HCWB may be in some trouble as it scores bad on both profitability and health. HCWB is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year HCWB has reported negative net income.
In the past year HCWB has reported a negative cash flow from operations.
HCWB had negative earnings in each of the past 5 years.
In the past 5 years HCWB always reported negative operating cash flow.
HCWB Yearly Net Income VS EBIT VS OCF VS FCFHCWB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -10M -20M -30M

1.2 Ratios

HCWB has a worse Return On Assets (-74.56%) than 62.55% of its industry peers.
Industry RankSector Rank
ROA -74.56%
ROE N/A
ROIC N/A
ROA(3y)-72.93%
ROA(5y)-57.75%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
HCWB Yearly ROA, ROE, ROICHCWB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 200 -200 400

1.3 Margins

The Gross Margin of HCWB (20.00%) is better than 72.47% of its industry peers.
HCWB does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 20%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
HCWB Yearly Profit, Operating, Gross MarginsHCWB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800 -1K

More info and screens

0

2. Health

2.1 Basic Checks

HCWB does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, HCWB has more shares outstanding
The number of shares outstanding for HCWB has been increased compared to 5 years ago.
The debt/assets ratio for HCWB is higher compared to a year ago.
HCWB Yearly Shares OutstandingHCWB Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 200K 400K 600K 800K 1M
HCWB Yearly Total Debt VS Total AssetsHCWB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

2.2 Solvency

HCWB has an Altman-Z score of -7.22. This is a bad value and indicates that HCWB is not financially healthy and even has some risk of bankruptcy.
HCWB has a worse Altman-Z score (-7.22) than 67.42% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -7.22
ROIC/WACCN/A
WACC8.22%
HCWB Yearly LT Debt VS Equity VS FCFHCWB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 20M -20M 40M

2.3 Liquidity

A Current Ratio of 0.11 indicates that HCWB may have some problems paying its short term obligations.
HCWB's Current ratio of 0.11 is on the low side compared to the rest of the industry. HCWB is outperformed by 96.82% of its industry peers.
HCWB has a Quick Ratio of 0.11. This is a bad value and indicates that HCWB is not financially healthy enough and could expect problems in meeting its short term obligations.
HCWB's Quick ratio of 0.11 is on the low side compared to the rest of the industry. HCWB is outperformed by 96.63% of its industry peers.
Industry RankSector Rank
Current Ratio 0.11
Quick Ratio 0.11
HCWB Yearly Current Assets VS Current LiabilitesHCWB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

More info and screens

4

3. Growth

3.1 Past

The earnings per share for HCWB have decreased strongly by -66.67% in the last year.
HCWB shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -57.71%.
The Revenue for HCWB have been decreasing by -11.50% on average. This is quite bad
EPS 1Y (TTM)-66.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-57.71%
Revenue growth 3Y-11.5%
Revenue growth 5YN/A
Sales Q2Q%-0.09%

3.2 Future

HCWB is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.92% yearly.
HCWB is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 141.38% yearly.
EPS Next Y16.94%
EPS Next 2Y35.37%
EPS Next 3Y22.04%
EPS Next 5Y13.92%
Revenue Next Year368.22%
Revenue Next 2Y89.2%
Revenue Next 3Y-25.99%
Revenue Next 5Y141.38%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
HCWB Yearly Revenue VS EstimatesHCWB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2022 2023 2024 2025 2028 2029 2030 200M 400M 600M
HCWB Yearly EPS VS EstimatesHCWB Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 -10 -20 -30

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

HCWB reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year HCWB is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
HCWB Price Earnings VS Forward Price EarningsHCWB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
HCWB Per share dataHCWB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -5 -10 -15 -20 -25

4.3 Compensation for Growth

HCWB's earnings are expected to grow with 22.04% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y35.37%
EPS Next 3Y22.04%

More info and screens

0

5. Dividend

5.1 Amount

HCWB does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

HCW BIOLOGICS INC

NASDAQ:HCWB (12/5/2025, 8:25:49 PM)

After market: 1.9 -0.08 (-4.04%)

1.98

-0.06 (-2.94%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-14 2025-11-14/amc
Earnings (Next)N/A N/A
Inst Owners4.8%
Inst Owner Change472.48%
Ins Owners27.29%
Ins Owner Change0%
Market Cap5.35M
Revenue(TTM)2.84M
Net Income(TTM)-21.55M
Analysts82.86
Price Target35.7 (1703.03%)
Short Float %2.42%
Short Ratio0.48
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.1%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 6.42
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-28
EYN/A
EPS(NY)-4.69
Fwd EYN/A
FCF(TTM)-4.71
FCFYN/A
OCF(TTM)-4.65
OCFYN/A
SpS0.31
BVpS-0.02
TBVpS-0.02
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -74.56%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 20%
FCFM N/A
ROA(3y)-72.93%
ROA(5y)-57.75%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 9.94%
Cap/Sales 18.2%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.11
Quick Ratio 0.11
Altman-Z -7.22
F-Score4
WACC8.22%
ROIC/WACCN/A
Cap/Depr(3y)665.42%
Cap/Depr(5y)407.44%
Cap/Sales(3y)127.14%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-66.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y16.94%
EPS Next 2Y35.37%
EPS Next 3Y22.04%
EPS Next 5Y13.92%
Revenue 1Y (TTM)-57.71%
Revenue growth 3Y-11.5%
Revenue growth 5YN/A
Sales Q2Q%-0.09%
Revenue Next Year368.22%
Revenue Next 2Y89.2%
Revenue Next 3Y-25.99%
Revenue Next 5Y141.38%
EBIT growth 1Y70.32%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y59.33%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y34.41%
OCF growth 3YN/A
OCF growth 5YN/A

HCW BIOLOGICS INC / HCWB FAQ

Can you provide the ChartMill fundamental rating for HCW BIOLOGICS INC?

ChartMill assigns a fundamental rating of 1 / 10 to HCWB.


Can you provide the valuation status for HCW BIOLOGICS INC?

ChartMill assigns a valuation rating of 1 / 10 to HCW BIOLOGICS INC (HCWB). This can be considered as Overvalued.


What is the profitability of HCWB stock?

HCW BIOLOGICS INC (HCWB) has a profitability rating of 1 / 10.


Can you provide the financial health for HCWB stock?

The financial health rating of HCW BIOLOGICS INC (HCWB) is 0 / 10.